United Kingdom· GB-APID-23858411000001108
Giotrif 30mg tablets
A afatinib product containing afatinib, registered in United Kingdom by Boehringer Ingelheim Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Afatinib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01EB03 (afatinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Afatinib · ATC L01EB03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of afatinib costs, country by country.
Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Afatinib · price per daily dose (40 mg)
USD · FX 28 Sept 2026
- CH Switzerland$199.66
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Afatinib
- Manufacturer
- Boehringer Ingelheim Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EB03
- ATC class
- Afatinib
- Defined daily dose
- 40 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5012816099029
- gtin5012816099463
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
170 interactions on record for afatinib.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Afatinib · interactions on record
170 records
- 10 severe
- 158 moderate
- 2 minor
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- Aminolevulinic acidL01XD04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Afatinib in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaGIOTRIFBOEHRINGER INGELHEIM (CANADA) LTD LTEE
- SwedenGIOTRIF 20 mg Filmdragerad tablettBoehringer Ingelheim International GmbH
- FranceGIOTRIF 20 mg, comprimé pelliculéBOEHRINGER INGELHEIM INTERNATIONAL
- IrelandGIOTRIF 20 mg film-coated tabletsBoehringer Ingelheim International GmbH
- NetherlandsGiotrif 20 mg, filmomhulde tablettenBoehringer Ingelheim International GmbH
- PolandGiotrifBoehringer Ingelheim International GmbH
- IcelandGiotrifBoehringer Ingelheim International GmbH*
- SwitzerlandGiotrif
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Cyprus · Afatinib Afatinib, Afatinib Sapiens
- Greece · Webrix
- Iceland · Giotrif
- Liechtenstein · Giotrif
- Latvia · Afatinib, Afatinib Lotus
- Malta · Afatinib Lotus
- Norway · Giotrif
- Sweden · Afatinib Lotus, Webrix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b51f7afa-aeab-4070-822e-2de1f5b748a6 GET /v1/drugs/b51f7afa-aeab-4070-822e-2de1f5b748a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "23858411000001108",
"desc": "Giotrif 30mg tablets (Boehringer Ingelheim Ltd)",
"form": "Oral tablet",
"vpid": "39726211000001106",
"source": "dmd",
"vtm_id": "774442002",
"strength": "30 mg",
"substance": "Afatinib",
"ingredient": "Afatinib dimaleate",
"supplier_code": "2065401000001103"
}See everything about afatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.